RAPT Therapeutics (RAPT) Shares Outstanding (Diluted Average): 2021-2024
Historic Shares Outstanding (Diluted Average) for Therapeutics (RAPT) over the last 4 years, with Sep 2024 value amounting to $38.9 million.
- Therapeutics' Shares Outstanding (Diluted Average) rose 1.42% to $38.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $38.9 million, marking a year-over-year increase of 1.42%. This contributed to the annual value of $38.3 million for FY2023, which is 17.82% up from last year.
- As of Q3 2024, Therapeutics' Shares Outstanding (Diluted Average) stood at $38.9 million, which was up 0.09% from $38.9 million recorded in Q2 2024.
- In the past 5 years, Therapeutics' Shares Outstanding (Diluted Average) registered a high of $38.9 million during Q3 2024, and its lowest value of $25.6 million during Q2 2021.
- For the 3-year period, Therapeutics' Shares Outstanding (Diluted Average) averaged around $36.1 million, with its median value being $38.3 million (2023).
- Data for Therapeutics' Shares Outstanding (Diluted Average) shows a peak YoY increased of 29.45% (in 2023) over the last 5 years.
- Quarterly analysis of 4 years shows Therapeutics' Shares Outstanding (Diluted Average) stood at $27.4 million in 2021, then rose by 18.80% to $32.5 million in 2022, then increased by 17.82% to $38.3 million in 2023, then increased by 1.42% to $38.9 million in 2024.
- Its Shares Outstanding (Diluted Average) stands at $38.9 million for Q3 2024, versus $38.9 million for Q2 2024 and $38.6 million for Q1 2024.